Cargando…

The Discovery of LOX-1, its Ligands and Clinical Significance

LOX-1 is an endothelial receptor for oxidized low-density lipoprotein (oxLDL), a key molecule in the pathogenesis of atherosclerosis.The basal expression of LOX-1 is low but highly induced under the influence of proinflammatory and prooxidative stimuli in vascular endothelial cells, smooth muscle ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimoto, Ryo, Fujita, Yoshiko, Kakino, Akemi, Iwamoto, Shin, Takaya, Tomohide, Sawamura, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204104/ https://www.ncbi.nlm.nih.gov/pubmed/21805404 http://dx.doi.org/10.1007/s10557-011-6324-6

Ejemplares similares

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)

Erratum to “Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox”: [Proc. Jpn. Acad., Ser. B 87, No. 3, 104–113]
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)

A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL
por: Kakino, Akemi, et al.
Publicado: (2019)

Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
por: Yokoyama, Chiharu, et al.
Publicado: (2016)

Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects
por: Kakino, Akemi, et al.
Publicado: (2020)

Detection of a High Ratio of Soluble to Membrane‐Bound LOX‐1 in Aspirated Coronary Thrombi From Patients With ST‐Segment–Elevation Myocardial Infarction
por: Lee, An‐Sheng, et al.
Publicado: (2020)

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study
por: Yokota, Chiaki, et al.
Publicado: (2016)

Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse model
por: Ohno, Marumi, et al.
Publicado: (2021)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE/AT1 complex on the cell membrane
por: Yokoyama, Serina, et al.
Publicado: (2021)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

Structure and Ligand Based Drug Design Strategies in the Development of Novel 5-LOX Inhibitors
por: Aparoy, Polamarasetty, et al.
Publicado: (2012)

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
por: Kattoor, Ajoe John, et al.
Publicado: (2019)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2
por: Ohno, Marumi, et al.
Publicado: (2021)

A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors
por: Hsu, Kai-Cheng, et al.
Publicado: (2020)

Discovery of an uncovered region in fibrin clots and its clinical significance
por: Hisada, Yohei, et al.
Publicado: (2013)

Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor
por: Chu, Chih-Sheng, et al.
Publicado: (2013)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments
por: Shaw, Daniel, et al.
Publicado: (2020)

Identification of the LOX Gene Family in Peanut and Functional Characterization of AhLOX29 in Drought Tolerance
por: Mou, Yifei, et al.
Publicado: (2022)

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease
por: Twigg, M. W, et al.
Publicado: (2012)

Characterization of Genetic Diversity and Linkage Disequilibrium of ZmLOX4 and ZmLOX5 Loci in Maize
por: De La Fuente, Gerald N., et al.
Publicado: (2013)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022)

LOX-1 and Angiotensin Receptors, and Their Interplay
por: Wang, Xianwei, et al.
Publicado: (2011)

Healthy hearts lay off LOX
por: Maxmen, Amy
Publicado: (2009)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

LOX and Its Methylation Impact Prognosis of Diseases and Correlate with TAM Infiltration in ESCA
por: Wu, Chuanqiang, et al.
Publicado: (2022)

“Affimer” synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
por: Roper, Barnaby W.R., et al.
Publicado: (2023)

Ecrg4 peptide is the ligand of multiple scavenger receptors
por: Moriguchi, Tetsuo, et al.
Publicado: (2018)

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

Koch's Discovery of the Tubercle Bacillus—Its Importance and Significance
por: Shrikhande, Y. G.
Publicado: (1932)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iqrcctu7mlj0bju82hn75jcc8k